Por favor, use este identificador para citar o enlazar este ítem:
http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2571
Título : | Laboratory-based surveillance of Streptococcus pneumoniae invasive disease in children in 10 Latin American countries: a SIREVA II project, 2000-2005 |
Creador: | Castañeda E |
Nivel de acceso: | Open access |
Palabras clave : | Antibacterianos - farmacologia - - niño - América Latina Técnicas de Tipificación Bacteriana Pruebas de Sensibilidad Microbiana Resistencia a las Penicilinas Infecciones Neumocócicas - epidemiologia - niño - América Latina Infecciones Neumocócicas - microbiologia Vigilancia de la Población - métodos - niño - América Latina Streptococcus pneumoniae - clasificación - niño - América Latina Streptococcus pneumoniae - efectos de drogas - niño - América Latina Streptococcus pneumoniae - aislamiento & purificación - niño - América Latina beta-Lactamas - farmacologia - niño - América Latina Anti-Bacterial Agents - pharmacology - child - Latin America Bacterial Typing Techniques Microbial Sensitivity Tests Penicillin Resistance Pneumococcal Infections - epidemiology - child - Latin America Pneumococcal Infections - microbiology - child - Latin America Population Surveillance - methods - child - Latin America Streptococcus pneumoniae - classification - child - Latin America Streptococcus pneumoniae - drug effects - child - Latin America Streptococcus pneumoniae - isolation & purification - child - Latin America beta-Lactams - pharmacology - child - Latin America Streptococcus pneumoniae, vigilancia, serotipos, Beta, susceptibilidad de betalactámicos, niños, América Latina, enfermedad invasiva Streptococcus pneumoniae, surveillance, serotypes, beta lactam susceptibility, children, Latin America, invasive disease |
Descripción : | For the last 14 years the Pan American Health Organization has been promoting surveillance of invasive pneumococcal disease in Latin American children for better understanding of the disease tendencies regarding capsular types circulation in each country and susceptibility to antimicrobials. METHODS: Laboratory-based surveillance data from 10 Latin American countries collected from 2000 to 2005 were analyzed, including serotype distribution and susceptibility to beta-lactam antibiotics. RESULTS: Although 61 different capsular types were identified during the 6-year surveillance, 13 serotypes accounted for 86% of all isolates. These were consistently the most prevalent throughout the study period with serotype 14 predominating. Diminished susceptibility to penicillin was detected in 38% of all Streptococcus pneumoniae isolates, with the highest prevalence in Dominican Republic and Mexico. Decreased susceptibility to penicillin increased in Brazil and Colombia whereas decreased high resistance rates was recorded in Chile. CONCLUSIONS: These data indicate that 10 countries of the Region continue to have high quality laboratory-based surveillance for pneumococcal disease thus generating valuable information so that healthcare decision makers may prioritize interventions. The heptavalent vaccine will potentially cover from 52.4% to 76.5% of strains causing invasive pneumococcal disease and the 13 valent from 76.7% to 88.3%. |
Colaborador(es) u otros Autores: | Agudelo CI Regueira M Corso A Brandileone MC Brandão AP Maldonado A Hormazabal JC Martínez IT Llanes R Sánchez J Feris JM Echaniz-Aviles G Carnalla-Barajas MN Terrazas MG Monroy IH Chamorro G Weiler N Camou T Gabarrot GG Spadola E Payares D Gabastou JM Di Fabio JL de la Hoz F SIREVA II Group. |
Fecha de publicación : | 2009 |
Tipo de publicación: | Artículo |
Formato: | |
Identificador del Recurso : | 10.1097/INF.0b013e3181a74b22 |
Fuente: | Pediatr Infect Dis J 28(9):e265-270 |
URI : | http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2571 |
Idioma: | eng |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.